AwardTape · Defense awards · Research and development · Health R&D · W911SR25CA006
W911SR25CA006: $206K definitive contract to Mark Cuban Cost Plus Drug Company, PBC
Mark Cuban Cost Plus Drug Company, PBC holds a definitive contract from Department of the Army with $206K obligated since Oct 2023, against a ceiling of $206K. Latest action Jun 11, 2025.
This contract is for proof of concept production of drug substance sterile saline and sterile water using nonsterile source water made under current good manufacturing practice regulations.
| PIID | W911SR25CA006 |
|---|---|
| Type | definitive contract |
| Company | Mark Cuban Cost Plus Drug Company, PBC |
| Agency | Department of the Army |
| Contracting office | W6QK ACC-APG |
| Category | Research and development · Health R&D |
| PSC | AN13 HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT |
| NAICS | 541714 RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) |
| Obligated since Oct 2023 | $206K |
| Total obligated (lifetime) | $206K |
| Ceiling (base and all options) | $206K |
| Base date | Jun 11, 2025 |
| Latest action | Jun 11, 2025 |
| End date | Dec 15, 2025 |
| Actions since Oct 2023 | 1 |
| Pricing | Firm fixed price |
| Competition | Competed after exclusion of sources |
| Place of performance | TX |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial